QNRF undergraduate research / UREP23-133-1-028
Synthesis and biological evaluation of imidazopyridines
as anticancer agents
A synthetic medicinal-chemistry project that evolved toward Schiff-base chemosensors and exploratory biological evaluation.
Scientific question
Heterocyclic chemistry, chemical sensing and early medicinal chemistry
The original plan proposed substituted imidazopyridines for biological evaluation. Its final report is scientifically interesting because it explicitly records the failure to achieve the proposed imidazopyridine synthesis through the intended route and the subsequent study of Schiff-base intermediates.
This is an example of a research question changing when chemistry does not behave as expected. The final report documents chemosensing work and exploratory anticancer investigations conducted collaboratively. It does not establish clinical efficacy, a validated drug mechanism or a successful imidazopyridine synthesis.
Student research role within a supervised Qatar University team. The original QNRF research plan and its final report document the project’s scientific development.
Methods and research design
- Microwave-assisted heterocyclic synthesis design
- Schiff-base synthesis, purification and UV–Vis/fluorescence analysis
- NMR, FTIR and mass-spectrometry-based structure elucidation (project methods)
- Exploratory breast-cancer cell assays and gene-expression studies by the collaborative team
Research record
Archived project final report: UREP23-133-1-028 (2021). Related chemical-sensing research in the broader group was published separately; no false paper–grant equivalence is implied.
For the first-person account of the route that failed, the subsequent imine sensing experiments and the preliminary biology, see The ring that never closed ↗. The grant dossier above remains the scientific source record.
← Back to all grant-supported projects